Methods related to minimally polarized functional units

Abstract

Provided herein are constructs of micro-aggregate multicellular, minimally polarized grafts containing Leucine-rich repeat-containing G-protein coupled Receptor (LGR) expressing cells for wound therapy applications, tissue engineering, cell therapy applications, regenerative medicine applications, medical/therapeutic applications, tissue healing applications, immune therapy applications, and tissue transplant therapy applications which preferably are associated with a delivery vector/substrate/support/scaffold for direct application.

I claim: 
     
       1. A method, comprising:
 a) separating fat and hypodermal elements from a mammalian tissue specimen ex vivo to provide remaining cutaneous elements containing an epidermal compartment, a dermal compartment, and a follicular compartment; 
 b) cutting through the epidermal compartment, the dermal compartment, and the follicular compartment to open the follicular compartment and prepare a cellular micro-aggregate comprising an epidermal segment, a dermal segment, and a segment of the follicular compartment, wherein the segments are interconnected and wherein the segment of the follicular compartment comprises living LGR-expressing stem cells that are exposed; and 
 c) culturing the cellular micro-aggregate to provide a composition. 
 
     
     
       2. The method of  claim 1 , wherein the living LGR-expressing stem cells comprise LGR4-expressing stem cells, LGR5 expressing stems cells, LGR6-expressing stem cells, or any combination thereof. 
     
     
       3. The method of  claim 1 , further comprising adding a cornification medium to the composition. 
     
     
       4. The method of  claim 1 , further comprising cryopreserving the composition. 
     
     
       5. A method, comprising applying the composition produced by the method of  claim 1  to a select target. 
     
     
       6. The method of  claim 5 , wherein the select target is selected from a tissue region, a wound, a void, a defective tissue, or any combination thereof. 
     
     
       7. The method of  claim 5 , wherein the applying is direct or indirect. 
     
     
       8. The method of  claim 5 , wherein the applying is direct and a delivery technique is selected from transplantation, implantation, directed seeding, directed migration, directed tracking, in setting, laminating, injection, or combinations thereof. 
     
     
       9. The method of  claim 1 , further comprising adding the composition to a pharmaceutically acceptable carrier. 
     
     
       10. The method of  claim 1 , wherein the mammalian tissue specimen is a human tissue specimen. 
     
     
       11. The method of  claim 1 , wherein b) comprises cutting through the epidermal compartment, the dermal compartment, and a bulge of the follicular compartment. 
     
     
       12. The method of  claim 1 , wherein b) comprises cutting through the epidermal compartment, the dermal compartment, and a bulb of the follicular compartment. 
     
     
       13. A method, comprising:
 a) separating fat and hypodermal elements from a mammalian tissue specimen ex vivo to provide remaining cutaneous elements containing an epidermal compartment, a dermal compartment, and a follicular compartment; 
 b) segmenting the epidermal compartment, the dermal compartment, and the follicular compartment to open the follicular compartment and prepare an epidermal segment, a dermal segment, and a segment of the follicular compartment, wherein the segments are interconnected and wherein the segment of the follicular compartment comprises living LGR-expressing stem cells that are exposed; and 
 c) culturing the epidermal segment, the dermal segment, and the segment of the follicular compartment to provide a composition. 
 
     
     
       14. The method of  claim 13 , wherein the living LGR-expressing stem cells comprise LGR4-expressing stem cells, LGR5 expressing stems cells, LGR6-expressing stem cells, or any combination thereof. 
     
     
       15. The method of  claim 13 , further comprising adding a cornification medium to the composition. 
     
     
       16. The method of  claim 13 , further comprising cryopreserving the composition. 
     
     
       17. A method, comprising applying the composition produced by the method of  claim 14  to a select target. 
     
     
       18. The method of  claim 17 , wherein the select target is selected from a tissue region, a wound, a void, a defective tissue, or any combination thereof. 
     
     
       19. The method of  claim 17 , wherein the applying is direct or indirect. 
     
     
       20. The method of  claim 17 , wherein the applying is direct and a delivery technique is selected from transplantation, implantation, directed seeding, directed migration, directed tracking, in setting, laminating, injection, or combinations thereof. 
     
     
       21. The method of  claim 13 , further comprising adding the composition to a pharmaceutically acceptable carrier. 
     
     
       22. The method of  claim 13 , wherein the mammalian tissue specimen is a human tissue specimen. 
     
     
       23. The method of  claim 13 , wherein b) comprises segmenting the epidermal compartment, the dermal compartment, and a bulge of the follicular compartment. 
     
     
       24. The method of  claim 13 , wherein b) comprises segmenting the epidermal compartment, the dermal compartment, and a bulb of the follicular compartment.